FOXO3 and Alzheimer disease: To further confirm this, we investigated its target foxo3a protein level by immunocytochemistry and found both total and nuclear foxo3a levels were increased in AD in vitro model cells compared to the WT cells, but both of them were reversed back to basal levels after the hASC extract treatment (Fig 4D and 4E).